Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Future Oncology (London, England)|December 5, 2015
The evolving understanding of small HER2-positive breast cancers: matching management to outcomesAdrienne G Waks, Sara M TolaneyCurrent Treatment Options in Oncology|March 30, 2023
Individualizing Curative-Intent Therapy in HER2-Positive Early-Stage Breast CancerOlga Martínez-Sáez, Adrienne G WaksJournal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and SafetyAdrienne G Waks, Ann H PartridgeNature Reviews. Clinical Oncology|September 13, 2024
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistanceAdrienne G Waks, Olga Martínez-Sáez, Paolo Tarantino, et al.Annals of Surgical Oncology|November 9, 2024
ASO Visual Abstract: Real-World Implications of the SOUND TrialAndreas Giannakou, Olga Kantor, Ko Un Park, et al.Annals of Surgical Oncology|October 14, 2024
Real-World Implications of the SOUND TrialAndreas Giannakou, Olga Kantor, Ko Un Park, et al.Breast Cancer Research and Treatment|October 1, 2015
Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factorsAdrienne G Waks, Sara M Tolaney, Alicia Galar, et al.Cancer|January 31, 2025
Outcomes and treatment patterns for stage I human epidermal growth factor receptor 2-positive breast cancer in the Surveillance, Epidemiology, and End Results database, 2010-2019Adrienne G Waks, Paolo Tarantino, Emily L Chen, et al.NPJ Breast Cancer|July 3, 2025
Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patientsXiaopeng Sun, Margaret L Axelrod, Adrienne G Waks, et al.Pageof 5